unknown
Stage
3
Investors
About
Develops droplet-based microfluidics instruments and platforms for single-cell screening, cell selection and antibody discovery, providing research instruments (e.g., Fluidity One‑M) to biotech and pharmaceutical customers. The company offers hardware and accompanying workflows to enable high-throughput isolation, analysis and sorting of individual cells in picodroplets.
Explore Sphere Bio (formerly Sphere Fluidics)'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.